Access cutting-edge small cell bladder cancer treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access small cell bladder cancer specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell bladder cancer treatment provided free
This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the pathologic complete response rate at cystectomy in patients after being treated with a combination therapy of atezolizumab, platinum, and etoposide.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Check if you qualify for this small cell bladder cancer clinical trial in Washington Dc, DC
If you're searching for small cell bladder cancer treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.